Leuner, K., Kurz, C., Guidetti, G., Orgogozo, J., & Mller, W
Infusion time is another factor
The increase in risk was small approximately three to four additional cases per 10,000 patients treated with GLP-1s over 18 months, but clinicians and patients should be aware of this potential association. Researchers said while the risk is low, the rising use of GLP-1s in patients with and without Type 2 diabetes warrants special attention to medication safety
This makes it particularly useful for those reducing meat intake or following plant-based diets where natural L-Carnitine consumption may be lower
N = 157) with normal Left Ventricular Ejection Fraction (LVEF) determined by echocardiography and Heart Failure patients (HF
If you stop taking them: You may regain weight previously lost Your blood sugar may increase (hyperglycemia) One clinical trial showed participants regained up to two-thirds of their lost weight within one year of stopping semaglutide